Lobbyist information

Amount

George Atanasov

$16,750.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 09/02/2016 Areas of focus will be any issues that impact Johnson & Johnson companies, including but not limited to medical device, consumer, pharmaceuticals, health care reform, wellness initiatives, tax and environment. Contacts related to these issues are expected to be made with the Executive Offices of the Governor and Lieutenant Governor, the Office of the Secretary of Health and Human Services, the Department of Public Health, the Health Policy Commission, and the Department of Environmental Protection.

Kevin Buckley

$23,093.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 Area of focus for 2016 will be any issues that impact Johnson & Johnson companies. These issues will likely include but not be limited to medical device, consumer, pharmaceutical, health care reform, wellness initiatives, tax, and environment. Bills or issues of likely focus: HB 2059 -Discount program for pharmaceuticals SB 1048 -Price control of prescription medication HB 2059 - An Act establishing a statewide discount program for pharmaceuticals HB 2073 - An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth HB 1910 - An Act relative to improved medication adherence. SB 1031 - An Act relative to improved medication adherence HB 1908 An Act relative to prescription recycling HB 1925 - An Act establishing provisions for the return of expired pharmaceuticals HB 1933 - An Act relative to safe disposal of medical sharps HB 1937 - An Act relative to the safe disposal of prescription drugs HB 1957 - An Act regarding sharps and medications HB 1986 - An Act providing for unused medication return by health care facilities HB 2022 - An Act relative to the safe disposal of prescription drugs HB 2103 – An Act Reducing the Misuse and Abuse of Prescription Drugs SB 1042 - An Act relative to responsible stewardship by drug manufacturers SB 1233 - An Act establishing and financing a drug collection and disposal program HB 693- An Act establishing the commission on extended producer responsibility. HB 3418 - An Act reducing packaging waste in the Commonwealth HB 1934 - An Act relative to micro-bead free waters Dykema HB 2063 - An Act relative to the manufacture or sale of personal care products and over-the-counter drugs containing microbeads SB 463 An Act to ensure microbead-free water HB 1701 - An Act relative to the judicial enforcement of noncompetition agreements SB 169 - An Act to protect trade secrets and eliminate non-compete agreements SB 957 - An Act relative to the judicial enforcement of noncompetition agreements An Act relative to the judicial enforcement of noncompetition agreements HB 1894 – An Act relative to retail pharmacy discounts and co-pay assistance HB 2477 - An Act closing a certain corporate tax haven loophole SB 1165 An Act relative to the dispensing of certain cancer related drugs SB 1186 - An Act to restore integrity in the marketing of pharmaceutical products and medical devices SB 1187 - An Act to prevent undue influence on prescriber behavior SB 1188 - An Act to reduce health care costs by promoting evidence-based prescriber education. FY 17 budget Continued Implementation of Chapter 224 Economic Development Policies

Total salaries paid:      $39,843.00

Lobbyist Entity information

Amount

ML Strategies, LLC	$48,217.75
Employed Terminated 01/01/2016

Total salaries paid:      $48,217.75

Expenditures

Amount